References
- Acocella G. Clinical pharmacokinetics of rifampicin. Clinical Pharmacokinetics 1978; 3: 108–127
- Della Bruna C., Schioppacassi G., Ungheri D., Jabes D., Morvillo E., Sanfilippo A. LM427, a new spiropiperidylrifamicin: ‘in vitro’ and ‘in vivo’ studies. Journal of Antibiotics 1983; 36: 1502–1506
- Fontana E., Giarda S., Vioglio S., Vicario G. P. Synthesis of carbon‐14 labelled spiro‐piperidyl‐rifamycins (LM118) and rifabutin (LM427). Journal of Labelled Compounds and Radiopharmaceuticals 1987; 24: 1341–1349
- Ghisalba O., Traxler P., Fuhrer H., Richter W. J. Early intermediates in the biosynthesis of ansamycins. II. Isolation and identification of proansamycin B‐M1 and proto‐rifamycin I‐M1. Journal of Antibiotics 1979; 32: 1267–1272
- Marsili L., Ballabio M., Franceschi G., Oronzo G., Vigevani A. Unusual rearrangement of 3‐hydrazino‐rifamycins leading to the enlargement of the ‘natural’ ansa bridge. Journal of Antibiotics 1982; 32: 1621–1623
- Martinelli E., Antonini P., Cricchio R., Lancini G., White R. J. Rifamycin R, a novel metabolite from a mutant of Nocardia mediterranea. Journal of Antibiotics 1978; 31: 949–951
- Nakagawa H., Sunahara S. Rifampicin‐glucuronide in human urine. Rifampicin, J. M. Dickinson. Excerpta Medica, Amsterdam 1974; 90–94
- Olliaro P., Strolin Benedetti M., Fanfani A., Repetto M. Rifabutine: activité et pharmacocinétique, Congrés International de Pneumologie (Alger). 1989
- Perucca E., Grimaldi G., Frigo G. M., Sardi A., Monig H., Ohnhaus E. E. A comparative study of the hepatic microsomal enzyme inducing properties of rifampicin and rifabutin in man. Acta Pharmacologica et Toxicologica 1986; 59(Suppl. 5)90
- Perucca E., Grimaldi R., Frigo G. M., Sardi A., Monig H., Ohnhaus E. E. Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects. European Journal of Clinical Pharmacology 1988; 34: 595–599
- Sanjuan M., Rovei V., Dow J., Benedetti Strolin M. Mass spectrometric studies of the metabolites of niaprazine. International Journal of Mass Spectrometry and Ion Physics 1983; 48: 93–96
- Segre G. Farmacocinetica. Rifampicina, A. Blasi, L. Donatelli, C. Zanussi. Minerva Medica, Turin 1978; 102–106
- Still W. C., Kahn M., Mitra A. Rapid chromatographic technique for preparative separations with moderate resolution. Journal of Organic Chemistry 1978; 43: 2923–2925
- Traxler P., Schupp T., Fuhrer H., Richter W. J. 3‐hydroxyrifamycin S and further novel ansamycins from a recombinant strain R‐21 of Nocardia mediterranei. Journal of Antibiotics 1981; 34: 971–979
- Ungheri D., Bruna Della C., Sanfilippo A. Activity of the spiropiperidyl rifamycin LM 427 on rifampicin resistant. Mycobacterium tuberculosis, Giornale Italiano di Chemioterapia 1984; 31: 211–214
- Ungheri D., Franceschi G., Bruna Della C. Proceedings of the 14th International Congress of Chemotherapy, J. Ishigami. University of Tokyo Press, Tokyo 1985; vol. 3: 1917–1918
- Ungheri D., Penati V., Giobbi A. Proceedings of the International Symposium on Mycobacieria of Clinical Interest, M. Casal. Elsevier, Amsterdam 1986; 184–187
- Vigevani A., Ballabio M., Gioia B., Marsili L., Vioglio S., Franceschi G. Identification of urinary metabolites of rifamycin LM427 in man. Journal of Antibiotics 1985; 38: 1799–1802